SCHEMBL8993437

SCHEMBL8993437

FCc1ncccc1C1=CCCC1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
F2RL1 P55085 2/20 0.40
PDE10A Q9Y233 2/20 0.36
KDR P35968 2/20 0.35
CCNE1 P24864 2/20 0.34
CDK2 P24941 2/20 0.34
PPARA Q07869 1/20 0.34
CYP1A2 P05177 1/20 0.33
GRM5 P41594 1/20 0.33
GRM2 Q14416 1/20 0.33
PTGS2 P35354 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CDK5 Q00535 1/20 0.32
PIM1 P11309 1/20 0.32
PSMB5 P28074 2/20 0.31
EED O75530 1/20 0.31
SUZ12 Q15022 1/20 0.31
EZH2 Q15910 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8993493 0.85 ALDH1A1 (0.46) F2RL1PDE10AKDRCCNE1CDK2
SCHEMBL25343836 0.75 F2RL1 (0.43) F2RL1PDE10AKDRCCNE1CDK2
SCHEMBL8993439 0.74 PIM1 (0.37) F2RL1PPARACYP1A2GRM5TDP1
SCHEMBL12030457 0.73 TDP1 (0.41) F2RL1PDE10AKDRCCNE1CDK2
SCHEMBL28758944 0.70 PTGS2 (0.51) F2RL1PDE10AKDRCCNE1CDK2
SCHEMBL15465246 0.70 MAP4K4 (0.41) F2RL1PDE10AKDRCCNE1CDK2
SCHEMBL15465608 0.70 PSMB5 (0.47) F2RL1PDE10AKDRCCNE1CDK2
SCHEMBL14152872 0.70 KDM4E (0.46) F2RL1PDE10ACCNE1CDK2CYP1A2
SCHEMBL5387804 0.68 PIM1 (0.39) F2RL1PPARACYP1A2GRM5TDP1
SCHEMBL8993654 0.67 F2RL1 (0.36) F2RL1KDRCCNE1CDK2GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0724566-A1 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-07 EP disclosed
WO-1995011883-A1 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-05-04 WO disclosed